Characterizing Pain Experiences: African American Patients With Multiple Myeloma Taking Around-the-Clock Opioids.
Characterizing Pain Experiences: African American Patients With Multiple Myeloma Taking Around-the-Clock Opioids.
复制标题
DOI：
10.1188/20.cjon.538-546
复制
发表时间：
2020-10-01
影响因子：
1.1
通讯作者：
Yeager, Katherine A.
中科院分区：
文献类型：
--
作者：
Belcher, Sarah M.;Bruner, Deborah Watkins;Hofmeister, Craig C.;Kweon, Jaime;Meghani, Salimah H.;Yeager, Katherine A.
多发性骨髓瘤患者会经历剧烈疼痛，可能需要使用阿片类药物治疗。尽管已知多发性骨髓瘤患病率和结果、癌症疼痛评估和种族疼痛治疗方面存在差异，但迄今为止的研究对非裔美国多发性骨髓瘤患者的疼痛特征的关注有限，特别是全天候服用阿片类药物的患者。旨在描述全天候服用阿片类药物的非裔美国多发性骨髓瘤患者的疼痛经历、对疼痛和疼痛控制的信念以及其他症状。对非裔美国癌症患者阿片类药物依从性的完整纵向研究的基线数据进行二次分析。使用描述性统计数据来描述样本、疼痛经历（简要疼痛量表）、关于疼痛和疼痛控制的信念（障碍问卷）以及相关症状（埃德蒙顿症状评估量表和患者健康问卷）。参与者 (n=34) 每天都会经历疼痛和其他症状，其中 50% 的人患有抑郁症。疼痛管理障碍包括不喜欢药物、害怕成瘾以及疼痛和药物带来的令人烦恼的副作用。未来更大规模的研究应该纳入可能导致该人群普遍疼痛和抑郁的高负担的多层次因素。
Patients with multiple myeloma experience severe pain that can necessitate treatment with opioids. Despite known disparities in multiple myeloma prevalence and outcomes, cancer pain assessment, and pain treatment by race, studies to date have paid limited attention to pain characterization among African American patients with multiple myeloma, particularly among patients taking around-the-clock opioids. To characterize the pain experience, beliefs about pain and pain control, and additional symptoms among African American patients with multiple myeloma taking around-the-clock opioids. Secondary analysis of baseline data from a completed longitudinal study of opioid adherence in African American patients with cancer. Descriptive statistics were used to characterize the sample, pain experience (Brief Pain Inventory), beliefs regarding pain and pain control (Barriers Questionnaire), and related symptoms (Edmonton Symptom Assessment Scale and Patient Health Questionnaire). Participants (n=34) experienced every day pain and additional symptoms, 50% of whom experienced depression. Pain management barriers included dislike of pills, fear of addiction, and bothersome side effects from pain and medication. Future larger studies should incorporate multi-level factors that may contribute to high burden of pervasive pain and depression among this population.